🚀 VC round data is live in beta, check it out!
Rockwell Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Rockwell Medical and similar public comparables like BPC Instruments, Nortech Systems, Prolight Diagnostics, Jin Medical International and more.
Rockwell Medical Overview
About Rockwell Medical
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
Founded
1996
HQ
Employees
244
Website
Sectors
Financials (LTM)
EV
$25M
Rockwell Medical Financials
Rockwell Medical reported last 12-month revenue of $70M and EBITDA of $694K.
In the same LTM period, Rockwell Medical generated $12M in gross profit, $694K in EBITDA, and had net loss of ($1M).
Revenue (LTM)
Rockwell Medical P&L
In the most recent fiscal year, Rockwell Medical reported revenue of $69M and EBITDA of $337K.
Rockwell Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $70M | XXX | $69M | XXX | XXX | XXX |
| Gross Profit | $12M | XXX | $12M | XXX | XXX | XXX |
| Gross Margin | 18% | XXX | 17% | XXX | XXX | XXX |
| EBITDA | $694K | XXX | $337K | XXX | XXX | XXX |
| EBITDA Margin | 1% | XXX | 1% | XXX | XXX | XXX |
| EBIT Margin | (6%) | XXX | (7%) | XXX | XXX | XXX |
| Net Profit | ($1M) | XXX | ($554K) | XXX | XXX | XXX |
| Net Margin | (1%) | XXX | (1%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Rockwell Medical Stock Performance
Rockwell Medical has current market cap of $35M, and enterprise value of $25M.
Market Cap Evolution
Rockwell Medical's stock price is $0.89.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $25M | $35M | 0.0% | XXX | XXX | XXX | $-0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialRockwell Medical Valuation Multiples
Rockwell Medical trades at 0.3x EV/Revenue multiple, and 35.4x EV/EBITDA.
EV / Revenue (LTM)
Rockwell Medical Financial Valuation Multiples
As of March 28, 2026, Rockwell Medical has market cap of $35M and EV of $25M.
Equity research analysts estimate Rockwell Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Rockwell Medical has a P/E ratio of (34.6x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $35M | XXX | $35M | XXX | XXX | XXX |
| EV (current) | $25M | XXX | $25M | XXX | XXX | XXX |
| EV/Revenue | 0.3x | XXX | 0.4x | XXX | XXX | XXX |
| EV/EBITDA | 35.4x | XXX | 72.9x | XXX | XXX | XXX |
| EV/EBIT | (6.2x) | XXX | (5.2x) | XXX | XXX | XXX |
| EV/Gross Profit | 2.0x | XXX | 2.1x | XXX | XXX | XXX |
| P/E | (34.6x) | XXX | (63.4x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (20.5x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Rockwell Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Rockwell Medical Margins & Growth Rates
Rockwell Medical's revenue in the last 12 month grew by 6%.
Rockwell Medical's revenue per employee in the last FY averaged $0.3M.
Rockwell Medical's rule of 40 is 7% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Rockwell Medical's rule of X is 16% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Rockwell Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 1% | XXX | 1% | XXX | XXX | XXX |
| EBITDA Growth | 215% | XXX | 450% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 7% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 16% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 3% | XXX | 3% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 20% | XXX | 20% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 24% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Rockwell Medical Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| BPC Instruments | XXX | XXX | XXX | XXX | XXX | XXX |
| Nortech Systems | XXX | XXX | XXX | XXX | XXX | XXX |
| Prolight Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Jin Medical International | XXX | XXX | XXX | XXX | XXX | XXX |
| Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Rockwell Medical M&A Activity
Rockwell Medical acquired XXX companies to date.
Last acquisition by Rockwell Medical was on XXXXXXXX, XXXXX. Rockwell Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Rockwell Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialRockwell Medical Investment Activity
Rockwell Medical invested in XXX companies to date.
Rockwell Medical made its latest investment on XXXXXXXX, XXXXX. Rockwell Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Rockwell Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Rockwell Medical
| When was Rockwell Medical founded? | Rockwell Medical was founded in 1996. |
| Where is Rockwell Medical headquartered? | Rockwell Medical is headquartered in United States. |
| How many employees does Rockwell Medical have? | As of today, Rockwell Medical has over 244 employees. |
| Who is the CEO of Rockwell Medical? | Rockwell Medical's CEO is Mark Strobeck. |
| Is Rockwell Medical publicly listed? | Yes, Rockwell Medical is a public company listed on Nasdaq. |
| What is the stock symbol of Rockwell Medical? | Rockwell Medical trades under RMTI ticker. |
| When did Rockwell Medical go public? | Rockwell Medical went public in 1998. |
| Who are competitors of Rockwell Medical? | Rockwell Medical main competitors are BPC Instruments, Nortech Systems, Prolight Diagnostics, Jin Medical International. |
| What is the current market cap of Rockwell Medical? | Rockwell Medical's current market cap is $35M. |
| What is the current revenue of Rockwell Medical? | Rockwell Medical's last 12 months revenue is $70M. |
| What is the current revenue growth of Rockwell Medical? | Rockwell Medical revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Rockwell Medical? | Current revenue multiple of Rockwell Medical is 0.3x. |
| Is Rockwell Medical profitable? | Yes, Rockwell Medical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Rockwell Medical? | Rockwell Medical's last 12 months EBITDA is $694K. |
| What is Rockwell Medical's EBITDA margin? | Rockwell Medical's last 12 months EBITDA margin is 1%. |
| What is the current EV/EBITDA multiple of Rockwell Medical? | Current EBITDA multiple of Rockwell Medical is 35.4x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.